These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25438877)

  • 1. Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.
    Noordraven EL; Audier CH; Staring AB; Wierdsma AI; Blanken P; van der Hoorn BE; Roijen LH; Mulder CL
    BMC Psychiatry; 2014 Dec; 14():343. PubMed ID: 25438877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
    Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of financial incentives on patients' motivation for treatment: results of "Money for Medication," a randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
    BMC Psychiatry; 2018 May; 18(1):144. PubMed ID: 29793451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial.
    Noordraven EL; Schermer MHN; Blanken P; Mulder CL; Wierdsma AI
    BMC Psychiatry; 2017 Aug; 17(1):313. PubMed ID: 28851345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).
    Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; Knapp M; McCabe R
    BMC Psychiatry; 2009 Sep; 9():61. PubMed ID: 19785727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.
    Priebe S; Bremner SA; Lauber C; Henderson C; Burns T
    Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
    BMC Res Notes; 2018 Sep; 11(1):655. PubMed ID: 30201054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of financial incentives on adherence to antipsychotic depot medication: does it change over time?
    Pavlickova H; Bremner SA; Priebe S
    J Clin Psychiatry; 2015 Aug; 76(8):e1029-34. PubMed ID: 26335089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.
    Henderson C; Knapp M; Yeeles K; Bremner S; Eldridge S; David AS; O'Connell N; Burns T; Priebe S
    PLoS One; 2015; 10(10):e0138816. PubMed ID: 26448540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Payment for accepting depot medication].
    Mulder CL; Noordraven E; Staring AB
    Ned Tijdschr Geneeskd; 2014; 158(4):A7309. PubMed ID: 24447676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.
    Priebe S; Yeeles K; Bremner S; Lauber C; Eldridge S; Ashby D; David AS; O'Connell N; Forrest A; Burns T
    BMJ; 2013 Oct; 347():f5847. PubMed ID: 24100934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Offering financial incentives to increase adherence to antipsychotic medication: the clinician experience.
    Highton-Williamson E; Barnicot K; Kareem T; Priebe S
    J Clin Psychopharmacol; 2015 Apr; 35(2):120-7. PubMed ID: 25692797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?
    Moran K; Priebe S
    Qual Life Res; 2016 Aug; 25(8):1897-902. PubMed ID: 26850023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial incentives to improve adherence to medication in five patients with schizophrenia in the Netherlands.
    Staring AB; Mulder CL; Priebe S
    Psychopharmacol Bull; 2010; 43(1):5-10. PubMed ID: 20581796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral.
    Patel MX; de Zoysa N; Bernadt M; David AS
    J Clin Psychiatry; 2008 Oct; 69(10):1548-56. PubMed ID: 19192437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of financial incentives for long-acting injectable antipsychotic adherence in patients with psychotic and bipolar disorders: a systematic review protocol.
    Dennis R; Christian R; Palokas M
    JBI Database System Rev Implement Rep; 2019 Jan; 17(1):43-48. PubMed ID: 30629042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.